Posts by John H. Kempen, MD, MPH, PhD, MHS
-
New Scoring System Predicts Risk of Cataract in Eyes with Anterior Uveitis
A team of Mass Eye and Ear researchers suggest maintaining good control of uveitis; preventing posterior synechiae, band keratopathy, and the need for glaucoma surgery; and minimizing the local steroid dose could be valuable for reducing cataract risk in eyes with anterior uveitis.
-
Consensus Guidelines: Initiating Antitubercular Therapy for Tubercular Uveitis
John H. Kempen, MD, MPH, PhD, MHS, director of Epidemiology in the Department of Ophthalmology, and colleagues in the Collaborative Ocular Tuberculosis Study Consensus Group led an international initiative to develop systematic recommendations about when to initiate antitubercular therapy for tubercular uveitis.
-
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
In the first study of its kind, Lucia Sobrin, MD, MPH, and John H. Kempen, MD, MPH, PhD, MHS, of the Massachusetts Eye and Ear/Mass General Hospital Department of Ophthalmology, and colleagues found a low risk of noninfectious uveitis among women using hormonal contraceptives or menopausal hormone replacement therapy.
Biography
A Professor of Ophthalmology, Part-time at Harvard Medical School, Director of Epidemiology and Senior Scholar at Mass Eye and Ear and the Schepens Eye Research Institute, Dr. Kempen is internationally renowned for his expertise in ocular inflammatory diseases and ophthalmic epidemiology. Dr. Kempen is Founding President of Sight for Souls—a Christian nonprofit organization that aims to eradicate global blindness by developing sustainable eye care delivery eye systems, providing public health outreach, and creating ophthalmology training programs in areas of greatest need. In 2015, Dr. Kempen began a long-term commitment to lead the organization’s first project personally—the establishment of the MyungSung Christian Medical Center Eye Institute (MEI) in Ethiopia. Dr. Kempen has doctoral training in epidemiology, and masters-level training in biostatistics and public health. He has completed research fellowships in clinical trials and in preventive ophthalmology. He is a fellow of the American Academy of Ophthalmology, and a member of the American Uveitis Society, the International Uveitis Study Group, the Society for Clinical Trials, and the Association for Research in Vision and Ophthalmology. He was appointed by President Bush to serve as a member of the Office of AIDS Research Advisory Council (2004-2008), and has approximately 150 publications in the leading journals of his specialty. He serves as the Editor-in-Chief of Ophthalmic Epidemiology.
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
